The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: Experience of a dialysis center in southeast Turkey

Basit Öğe Kaydı
dc.contributor.authorKayabasi, Hasan
dc.contributor.authorSit, Dede
dc.contributor.authorKadiroglu, Ali Kemal
dc.contributor.authorKara, Ismail Hamdi
dc.contributor.authorYilmaz, Mehmet Emin
dc.date.accessioned2024-04-24T16:24:39Z
dc.date.available2024-04-24T16:24:39Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstractTuberculosis remains a significant health problem for patients receiving chronic dialysis. The purpose of this study was to evaluate the prevalence, clinical characteristics, and outcomes of tuberculosis among patients with end-stage renal failure (ESRF) undergoing chronic hemodialysis and continuous ambulatory peritoneal dialysis. Between 1999 and 2006, we diagnosed 21 active tuberculosis patients among a total of 674-dialysis patient in our dialysis center (582 patients on hemodialysis and 92 patients on continuous ambulatory peritoneal dialysis program). Fourteen patients developed extrapulmonary tuberculosis (generally tuberculous lymphadenitis, n = 8) and seven patients developed pulmonary tuberculosis. All patients who developed tuberculosis after starting dialysis had low creatinine clearances and, in general, anemia and hypoalbuminemia. Three of patients greater than 40 years died. In conclusion, tuberculous lymphadenitis was the most frequent form of extrapulmonary tuberculosis in our dialysis population. If no cause is found despite extensive investigations in an end stage renal failure case with fever, loss of weight, and/or atypical lymphadenopathy, the physician should consider the possibility of tuberculosis. Finally, it was considered that ESRF is associated with depressed immune system and elevated risk of tuberculosis; thus, in this population, clinicians must evaluate patients carefully.en_US
dc.identifier.doi10.1080/08860220802064721
dc.identifier.endpage519en_US
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.issue5en_US
dc.identifier.pmid18569932
dc.identifier.scopus2-s2.0-45749100446
dc.identifier.scopusqualityQ2
dc.identifier.startpage513en_US
dc.identifier.urihttps://doi.org/10.1080/08860220802064721
dc.identifier.urihttps://hdl.handle.net/11468/16805
dc.identifier.volume30en_US
dc.identifier.wosWOS:000257070000007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofRenal Failure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTuberculosisen_US
dc.subjectMycobacterium Tuberculosisen_US
dc.subjectDialysisen_US
dc.subjectEnd Stage Renal Failureen_US
dc.titleThe prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: Experience of a dialysis center in southeast Turkeyen_US
dc.titleThe prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: Experience of a dialysis center in southeast Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu